{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T02:16:42Z","timestamp":1784254602709,"version":"3.55.0"},"reference-count":90,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T00:00:00Z","timestamp":1645747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p>The treatment of hypertension and heart failure remains a major challenge to healthcare providers. Despite therapeutic advances, heart failure affects more than 26 million people worldwide and is increasing in prevalence due to an ageing population. Similarly, despite an improvement in blood pressure management, largely due to pharmacological interventions, hypertension remains a silent killer. This is in part due to its ability to contribute to heart failure. Development of novel therapies will likely be at the forefront of future cardiovascular studies to address these unmet needs. Calcitonin gene-related peptide (CGRP) is a 37 amino acid potent vasodilator with positive-ionotropic and -chronotropic effects. It has been reported to have beneficial effects in hypertensive and heart failure patients. Interestingly, changes in plasma CGRP concentration in patients after myocardial infarction, heart failure, and in some forms of hypertension, also support a role for CGRP on hemodynamic functions. Rodent studies have played an important role thus far in delineating mechanisms involved in CGRP-induced cardioprotection. However, due to the short plasma half-life of CGRP, these well documented beneficial effects have often proven to be acute and transient. Recent development of longer lasting CGRP agonists may therefore offer a practical solution to investigating CGRP further in cardiovascular disease <jats:italic>in vivo<\/jats:italic>. Furthermore, pre-clinical murine studies have hinted at the prospect of cardioprotective mechanisms of CGRP which is independent of its hypotensive effect. Here, we discuss past and present evidence of vascular-dependent and -independent processes by which CGRP could protect the vasculature and myocardium against cardiovascular dysfunction.<\/jats:p>","DOI":"10.3389\/fphys.2022.833645","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T08:25:32Z","timestamp":1645777532000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["The Vascular-Dependent and -Independent Actions of Calcitonin Gene-Related Peptide in Cardiovascular Disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Fulye","family":"Argunhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan D.","family":"Brain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/S1474-4422(20)30282-9","article-title":"Targeting CGRP in migraine: a matter of choice and dose.","volume":"19","author":"Al-Hassany","year":"2020","journal-title":"Lancet Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1126\/science.2994212","article-title":"Expression in brain of a messenger RNA encoding a novel neuropeptide homologous to calcitonin gene-related peptide.","volume":"229","author":"Amara","year":"1985","journal-title":"Science"},{"key":"B3","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/298240a0","article-title":"Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products.","volume":"298","author":"Amara","year":"1982","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1161\/HYPERTENSIONAHA.120.14851","article-title":"Calcitonin gene-related peptide protects against cardiovascular dysfunction independently of nitric oxide In Vivo.","volume":"77","author":"Argunhan","year":"2021","journal-title":"Hypertension"},{"key":"B5","doi-asserted-by":"publisher","first-page":"5732","DOI":"10.1038\/ncomms6732","article-title":"TRPA1 is essential for the vascular response to environmental cold exposure.","volume":"5","author":"Aubdool","year":"2014","journal-title":"Nat. Commun."},{"key":"B6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1161\/circulationaha.117.028388","article-title":"A novel alpha-calcitonin gene-related peptide analogue protects against end-organ damage in experimental hypertension, cardiac hypertrophy, and heart failure.","volume":"136","author":"Aubdool","year":"2017","journal-title":"Circulation"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1097\/00005344-199406000-00021","article-title":"Calcitonin gene-related peptide stimulates a positive contractile response in rat ventricular cardiomyocytes.","volume":"23","author":"Bell","year":"1994","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1006\/jmcc.1995.0231","article-title":"Hypertrophic effects of calcitonin gene-related peptide (Cgrp) and amylin on adult mammalian ventricular cardiomyocytes.","volume":"27","author":"Bell","year":"1995","journal-title":"J. Mol. Cell Cardiol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-021-02678-8","article-title":"Myocardial perfusion recovery induced by an alpha-calcitonin gene-related peptide analogue.","author":"Bentsen","year":"2021","journal-title":"J. Nucl. Cardiol."},{"key":"B10","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/bcp.12591","article-title":"Therapeutic antibodies against CGRP or its receptor.","volume":"79","author":"Bigal","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.15420\/cfr.2019.11.2","article-title":"Inotropes in acute heart failure: from guidelines to practical use: therapeutic options and clinical practice.","volume":"5","author":"Bistola","year":"2019","journal-title":"Card. Fail. Rev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1152\/physrev.00037.2003","article-title":"Vascular actions of calcitonin gene-related peptide and adrenomedullin.","volume":"84","author":"Brain","year":"2004","journal-title":"Physiol. Rev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/1523-1747.ep12455620","article-title":"Potent vasodilator activity of calcitonin gene-related peptide in human skin.","volume":"87","author":"Brain","year":"1986","journal-title":"J. Invest. Dermatol."},{"key":"B14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/313054a0","article-title":"Calcitonin gene-related peptide is a potent vasodilator.","volume":"313","author":"Brain","year":"1985","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","first-page":"f55","DOI":"10.1136\/bmj.f55","article-title":"Benefits of beta blockers in patients with heart failure and reduced ejection fraction: network meta-analysis.","volume":"346","author":"Chatterjee","year":"2013","journal-title":"BMJ"},{"key":"B16","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s42003-021-02293-w","article-title":"CGRP, adrenomedullin and adrenomedullin 2 display endogenous Gpcr agonist bias in primary human cardiovascular cells.","volume":"4","author":"Clark","year":"2021","journal-title":"Commun. Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1476-5381.1990.tb14656.x","article-title":"Action of calcitonin gene-related peptide upon bovine vascular endothelial and smooth muscle cells grown in isolation and co-culture.","volume":"99","author":"Crossman","year":"1990","journal-title":"Br. J. Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41582-018-0003-1","article-title":"CGRP as the target of new migraine therapies - successful translation from bench to clinic.","volume":"14","author":"Edvinsson","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/305534a0","article-title":"Stimulation of noradrenergic sympathetic outflow by calcitonin gene-related peptide.","volume":"305","author":"Fisher","year":"1983","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1476-5381.1991.tb12201.x","article-title":"Calcitonin gene-related peptide and human epicardial coronary arteries: presence, release and vasodilator effects.","volume":"102","author":"Franco-Cereceda","year":"1991","journal-title":"Br. J. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000028339","article-title":"Potential of calcitonin gene-related peptide in coronary heart disease.","volume":"60","author":"Franco-Cereceda","year":"2000","journal-title":"Pharmacology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/0196-9781(87)90117-3","article-title":"Calcitonin gene-related peptide (CGRP) in capsaicin-sensitive substance P-immunoreactive sensory neurons in animals and man: distribution and release by capsaicin.","volume":"8","author":"Franco-Cereceda","year":"1987","journal-title":"Peptides"},{"key":"B23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/00004872-199102000-00013","article-title":"The antihypertensive effect of calcitonin gene-related peptide in rats with norepinephrine- and angiotensin II-induced hypertension.","volume":"9","author":"Fujioka","year":"1991","journal-title":"J. Hypertens."},{"key":"B24","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1161\/01.hyp.29.1.248","article-title":"Calcitonin gene-related peptide is a depressor in NG-nitro-L-arginine methyl ester-induced hypertension during pregnancy.","volume":"29","author":"Gangula","year":"1997","journal-title":"Hypertension"},{"key":"B25","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1161\/01.hyp.35.1.470","article-title":"Increased blood pressure in alpha-calcitonin gene-related peptide\/calcitonin gene knockout mice.","volume":"35","author":"Gangula","year":"2000","journal-title":"Hypertension"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1111\/j.1476-5381.1991.tb12333.x","article-title":"Haemodynamic effects of human alpha-calcitonin gene-related peptide following administration of endothelin-1 or NG-nitro-L-arginine methyl ester in conscious rats.","volume":"103","author":"Gardiner","year":"1991","journal-title":"Br. J. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/BF02554909","article-title":"Cardiovascular action of calcitonin gene-related peptide in humans.","volume":"37","author":"Gennari","year":"1985","journal-title":"Calcif. Tissue Int."},{"key":"B28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/cvr\/24.3.239","article-title":"Improved cardiac performance with human calcitonin gene related peptide in patients with congestive heart failure.","volume":"24","author":"Gennari","year":"1990","journal-title":"Cardiovasc. Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1523\/JNEUROSCI.04-12-03101.1984","article-title":"Calcitonin gene-related peptide immunoreactivity in the spinal cord of man and of eight other species.","volume":"4","author":"Gibson","year":"1984","journal-title":"J. Neurosci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/s0140-6736(85)90059-5","article-title":"Calcitonin gene-related peptide: potent vasodilator and major product of calcitonin gene.","volume":"2","author":"Girgis","year":"1985","journal-title":"Lancet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1476-5381.1992.tb14508.x","article-title":"Human alpha-calcitonin gene-related peptide stimulates adenylate cyclase and guanylate cyclase and relaxes rat thoracic aorta by releasing nitric oxide.","volume":"107","author":"Gray","year":"","journal-title":"Br. J. Pharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0014-2999(92)90069-g","article-title":"Nitric oxide synthesis inhibitors attenuate calcitonin gene-related peptide endothelium-dependent vasorelaxation in rat aorta.","volume":"212","author":"Gray","year":"","journal-title":"Eur. J. Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1161\/01.res.73.3.579","article-title":"Peptidergic innervation of human epicardial coronary arteries.","volume":"73","author":"Gulbenkian","year":"1993","journal-title":"Circ. Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1073\/pnas.87.9.3299","article-title":"Calcitonin gene-related peptide stimulates proliferation of human endothelial cells.","volume":"87","author":"Haegerstrand","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bph.14075","article-title":"Update on the pharmacology of calcitonin\/Cgrp family of peptides: iuphar review 25.","volume":"175","author":"Hay","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"R259","DOI":"10.1152\/ajpregu.1999.276.1.R259","article-title":"Ca2+-induced Ca2+ release involved in positive inotropic effect mediated by Cgrp in ventricular myocytes.","volume":"276","author":"Huang","year":"1999","journal-title":"Am. J. Physiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"S418","DOI":"10.1097\/00004872-198812040-00131","article-title":"The interaction of calcitonin gene-related peptide with angiotensin Ii on blood pressure and renin release.","volume":"6","author":"Itabashi","year":"1988","journal-title":"J. Hypertens. Suppl."},{"key":"B38","doi-asserted-by":"publisher","first-page":"eabf7258","DOI":"10.1126\/science.abf7258","article-title":"Structure and dynamics of the Cgrp receptor in apo and peptide-bound forms.","volume":"372","author":"Josephs","year":"2021","journal-title":"Science"},{"key":"B39","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/s0008-6363(98)00016-9","article-title":"Calcitonin gene-related peptide in myocardial ischaemia and reperfusion in the pig.","volume":"38","author":"Kallner","year":"1998","journal-title":"Cardiovasc. Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1161\/01.RES.0000152969.42117.ca","article-title":"Calcitonin gene-related peptide in vivo positive inotropy is attributable to regional sympatho-stimulation and is blunted in congestive heart failure.","volume":"96","author":"Katori","year":"2005","journal-title":"Circ. Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1254\/JP.88.39","article-title":"Regulation of vascular function by perivascular calcitonin gene-related peptide-containing nerves","volume":"88","author":"Kawasaki","year":"2002","journal-title":"Jpn. J. Pharmacol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1254\/jjp.79.221","article-title":"Long-term treatment with angiotensin converting enzyme inhibitor restores reduced calcitonin gene-related peptide-containing vasodilator nerve function in mesenteric artery of spontaneously hypertensive rats.","volume":"79","author":"Kawasaki","year":"1999","journal-title":"Jpn. J. Pharmacol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1161\/01.res.67.3.733","article-title":"Age-related decrease of calcitonin gene-related peptide-containing vasodilator innervation in the mesenteric resistance vessel of the spontaneously hypertensive rat.","volume":"67","author":"Kawasaki","year":"1990","journal-title":"Circ. Res."},{"key":"B44","first-page":"508","article-title":"Angiotensin inhibits neurotransmission of calcitonin gene-related peptide-containing vasodilator nerves in mesenteric artery of spontaneously hypertensive rats.","volume":"284","author":"Kawasaki","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3389\/fphys.2018.01249","article-title":"The role of calcitonin gene related peptide (CGRP) in neurogenic vasodilation and its cardioprotective effects.","volume":"9","author":"Kee","year":"2018","journal-title":"Front. Physiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0167-0115(85)90013-8","article-title":"Infusion of a novel peptide, calcitonin gene-related peptide (CGRP) in man. Pharmacokinetics and effects on gastric acid secretion and on gastrointestinal hormones.","volume":"10","author":"Kraenzlin","year":"1985","journal-title":"Regul. Pept."},{"key":"B47","doi-asserted-by":"publisher","first-page":"602952","DOI":"10.3389\/fphar.2020.602952","article-title":"A novel alginate-based delivery system for the prevention and treatment of pressure-overload induced heart failure.","volume":"11","author":"Kumar","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3389\/fphys.2019.00821","article-title":"Protective role of alpha-calcitonin gene-related peptide in cardiovascular diseases.","volume":"10","author":"Kumar","year":"","journal-title":"Front. Physiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e14269","DOI":"10.14814\/phy2.14269","article-title":"Alpha-calcitonin gene-related peptide prevents pressure-overload induced heart failure: role of apoptosis and oxidative stress.","volume":"7","author":"Kumar","year":"","journal-title":"Physiol. Rep."},{"key":"B50","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/00004872-200501000-00020","article-title":"Development of angiotensin II-induced hypertension: role of CGRP and its receptor.","volume":"23","author":"Li","year":"2005","journal-title":"J. Hypertens."},{"key":"B51","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.regpep.2013.06.008","article-title":"Alpha-calcitonin gene-related peptide is protective against pressure overload-induced heart failure.","volume":"185","author":"Li","year":"2013","journal-title":"Regul. Pept."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1097\/01.hjh.0000125409.50839.f1","article-title":"Activation of the renin-angiotensin system in alpha-calcitonin gene-related peptide\/calcitonin gene knockout mice.","volume":"22","author":"Li","year":"2004","journal-title":"J. Hypertens."},{"key":"B53","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/s0143-4179(97)90046-9","article-title":"The antiproliferative effects of calcitonin gene-related peptide in different passages of cultured vascular smooth muscle cells.","volume":"31","author":"Li","year":"1997","journal-title":"Neuropeptides"},{"key":"B54","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41586-018-0535-y","article-title":"Cryo-EM structure of the active, Gs-protein complexed, human Cgrp receptor.","volume":"561","author":"Liang","year":"2018","journal-title":"Nature"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2053149","DOI":"10.1155\/2019\/2053149","article-title":"Cgrp reduces apoptosis of DRG cells induced by high-glucose oxidative stress injury through PI3K\/AKT induction of heme oxygenase-1 and Nrf-2 expression.","volume":"2019","author":"Liu","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"key":"B56","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jash.2014.03.001","article-title":"Calcitonin gene-related peptide (CGRP) in autonomic cardiovascular regulation and vascular structure.","volume":"8","author":"Mai","year":"2014","journal-title":"J. Am. Soc. Hypertens."},{"key":"B57","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure.","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"B58","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/30666","article-title":"RAMPS regulate the transport and ligand specificity of the calcitonin-receptor-like receptor.","volume":"393","author":"McLatchie","year":"1998","journal-title":"Nature"},{"key":"B59","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41586-020-2890-8","article-title":"Paracrine signalling by cardiac calcitonin controls atrial fibrogenesis and arrhythmia.","volume":"587","author":"Moreira","year":"2020","journal-title":"Nature"},{"key":"B60","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/344770a0","article-title":"Arterial dilations in response to calcitonin gene-related peptide involve activation of K+ channels.","volume":"344","author":"Nelson","year":"1990","journal-title":"Nature"},{"key":"B61","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ejphar.2016.01.003","article-title":"Long acting analogue of the calcitonin gene-related peptide induces positive metabolic effects and secretion of the glucagon-like peptide-1.","volume":"773","author":"Nilsson","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/s0014-2999(98)00400-2","article-title":"Effect of adrenomedullin on cAMP and cGMP levels in rat cardiac myocytes and nonmyocytes.","volume":"353","author":"Nishikimi","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/hh2301.100812","article-title":"Elevated sympathetic nervous activity in mice deficient in alphacgrp.","volume":"89","author":"Oh-hashi","year":"2001","journal-title":"Circ. Res."},{"key":"B64","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1161\/CIR.0000000000000426","article-title":"Drugs that may cause or exacerbate heart failure: a scientific statement from the american heart association.","volume":"134","author":"Page","year":"2016","journal-title":"Circulation"},{"key":"B65","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/bs.apha.2020.01.001","article-title":"RAMPs as allosteric modulators of the calcitonin and calcitonin-like class B G protein-coupled receptors.","volume":"88","author":"Pioszak","year":"2020","journal-title":"Adv. Pharmacol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/164_2019_204","article-title":"Understanding CGRP and cardiovascular risk","volume":"255","author":"Rubio-Beltran","year":"2019","journal-title":"Handb. Exp. Pharmacol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1152\/physrev.00034.2013","article-title":"Calcitonin gene-related peptide: physiology and pathophysiology.","volume":"94","author":"Russell","year":"2014","journal-title":"Physiol. Rev."},{"key":"B68","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1177\/0271678X17751352","article-title":"Increased receptor activity-modifying protein 1 in the nervous system is sufficient to protect against autonomic dysregulation and hypertension.","volume":"39","author":"Sabharwal","year":"2019","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B69","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1161\/HYPERTENSIONAHA.109.148171","article-title":"Receptor activity-modifying protein 1 increases baroreflex sensitivity and attenuates Angiotensin-induced hypertension.","volume":"55","author":"Sabharwal","year":"2010","journal-title":"Hypertension"},{"key":"B70","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/head.14051","article-title":"Hypertension: A new safety risk for patients treated with erenumab.","volume":"61","author":"Saely","year":"2021","journal-title":"Headache"},{"key":"B71","doi-asserted-by":"publisher","first-page":"170677","DOI":"10.1016\/j.peptides.2021.170677","article-title":"Calcitonin gene-related peptide exerts inhibitory effects on autophagy in the heart of mice.","volume":"146","author":"Schavinski","year":"2021","journal-title":"Peptides"},{"key":"B72","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/0002-9149(91)90531-o","article-title":"Effects of prolonged infusion of human alpha calcitonin gene-related peptide on hemodynamics, renal blood flow and hormone levels in congestive heart failure.","volume":"67","author":"Shekhar","year":"1991","journal-title":"Am. J. Cardiol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1161\/CIRCRESAHA.119.315429","article-title":"Blood pressure normalization-independent cardioprotective effects of endogenous, physical activity-induced alphaCGRP (alpha calcitonin gene-related peptide) in chronically hypertensive mice.","volume":"125","author":"Skaria","year":"2019","journal-title":"Circ. Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1161\/HYPERTENSIONAHA.113.02517","article-title":"An ongoing role of alpha-calcitonin gene-related peptide as part of a protective network against hypertension, vascular hypertrophy, and oxidative stress.","volume":"63","author":"Smillie","year":"2014","journal-title":"Hypertension"},{"key":"B75","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0014-5793(85)80820-6","article-title":"A second human calcitonin\/CGRP gene.","volume":"183","author":"Steenbergh","year":"1985","journal-title":"FEBS Lett."},{"key":"B76","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1042\/cs0700389","article-title":"Human calcitonin gene related peptide: a potent endogenous vasodilator in man.","volume":"70","author":"Struthers","year":"1986","journal-title":"Clin. Sci. (Lond)"},{"key":"B77","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.yjmcc.2005.09.008","article-title":"Antiapoptotic effect of calcitonin gene-related peptide on oxidative stress-induced injury in H9c2 cardiomyocytes via the Ramp1\/Crlr complex.","volume":"39","author":"Sueur","year":"2005","journal-title":"J. Mol. Cell Cardiol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1161\/01.HYP.0000151130.34874.fa","article-title":"Calcitonin gene-related peptide protects against hypertension-induced heart and kidney damage.","volume":"45","author":"Supowit","year":"2005","journal-title":"Hypertension"},{"key":"B79","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1161\/01.hyp.29.4.945","article-title":"Calcitonin gene-related peptide is a depressor of deoxycorticosterone-salt hypertension in the rat.","volume":"29","author":"Supowit","year":"1997","journal-title":"Hypertension"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1161\/01.hyp.26.6.1177","article-title":"Regulation of neuronal calcitonin gene-related peptide expression. Role of increased blood pressure.","volume":"26","author":"Supowit","year":"1995","journal-title":"Hypertension"},{"key":"B81","doi-asserted-by":"publisher","first-page":"15031","DOI":"10.1038\/ncomms15031","article-title":"FRET biosensor uncovers camp nano-domains at beta-adrenergic targets that dictate precise tuning of cardiac contractility.","volume":"8","author":"Surdo","year":"2017","journal-title":"Nat. Commun."},{"key":"B82","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10072-019-03769-8","article-title":"Cgrp and headache: a brief review.","volume":"40","author":"Tepper","year":"2019","journal-title":"Neurol. Sci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"e70153","DOI":"10.7554\/eLife.70153","article-title":"Dysfunctional Trpm8 signalling in the vascular response to environmental cold in ageing.","volume":"10","author":"Thapa","year":"2021","journal-title":"eLife"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.jacc.2009.05.015","article-title":"The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.","volume":"54","author":"Triposkiadis","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"16702","DOI":"10.1073\/pnas.0705974104","article-title":"Hypertension and dysregulated proinflammatory cytokine production in receptor activity-modifying protein 1-deficient mice.","volume":"104","author":"Tsujikawa","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B86","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.tips.2010.06.006","article-title":"Regulation of signal transduction by calcitonin gene-related peptide receptors.","volume":"31","author":"Walker","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"B87","doi-asserted-by":"crossref","first-page":"21925","DOI":"10.1074\/jbc.M116.751362","article-title":"Receptor activity-modifying protein-directed G protein signaling specificity for the calcitonin gene-related peptide family of receptors.","volume":"291","author":"Weston","year":"2016","journal-title":"J. Biol. Chem."},{"key":"B88","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1476-5381.2009.00185.x","article-title":"cAMP signal transduction in the heart: understanding spatial control for the development of novel therapeutic strategies.","volume":"158","author":"Zaccolo","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1113\/jphysiol.2003.048207","article-title":"Cardiac vanilloid receptor 1-expressing afferent nerves and their role in the cardiogenic sympathetic reflex in rats.","volume":"551","author":"Zahner","year":"2003","journal-title":"J. Physiol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1161\/CIRCRESAHA.114.305892","article-title":"Cardiac hypertrophy is inhibited by a local pool of cAMP regulated by phosphodiesterase 2.","volume":"117","author":"Zoccarato","year":"2015","journal-title":"Circ. Res."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2022.833645\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T08:25:38Z","timestamp":1645777538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2022.833645\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,25]]},"references-count":90,"alternative-id":["10.3389\/fphys.2022.833645"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2022.833645","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,25]]},"article-number":"833645"}}